Form4insider filings, from the source

SEC Form 4 · accession 0000911916-15-000187

CoLucid Pharmaceuticals, Inc. · CLCD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Richard J Markham
Director · 10% Owner
Period of report
May 11, 2015
Accepted (ET)
May 12, 2015 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3May 11, 2015C1,520,136—A1,520,136IBy Care Capital Investments III, LP
Common StockF1,F2,F4May 11, 2015C25,403—A25,403IBy Care Capital Offshore Investments III, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B Convertible Preferred StockF2,F3,F1,F5—May 11, 2015C1,199,841D——Common Stock1,199,8410I
Series B Convertible Preferred StockF2,F4,F1,F5—May 11, 2015C20,050D——Common Stock20,0500I
Series C Convertible Preferred StockF2,F3,F1,F5—May 11, 2015C320,295D——Common Stock320,2950I
Series C Convertible Preferred StockF2,F4,F1,F5—May 11, 2015C5,353D——Common Stock5,3530I

Explanation of responses